Direct modulation of pancreatic CCK receptors and enzyme secretion by insulin in isolated pancreatic acini from diabetic rats

Diabetes ◽  
1983 ◽  
Vol 32 (3) ◽  
pp. 241-246 ◽  
Author(s):  
M. Otsuki ◽  
J. A. Williams
1995 ◽  
Vol 268 (3) ◽  
pp. E531-E536 ◽  
Author(s):  
M. Otsuki ◽  
T. Akiyama ◽  
H. Shirohara ◽  
S. Nakano ◽  
K. Furumi ◽  
...  

Pancreatic exocrine function of a new inbred strain Otsuka Long-Evans Tokushima Fatty (OLETF) rat that develops spontaneous persistent hyperglycemia was evaluated in in vitro isolated pancreatic acini and compared with that in the control Long-Evans Tokushima Otsuka (LETO) rat. Serum glucose and insulin concentrations in the OLETF rats were significantly high (glucose: 270 +/- 12 vs. 208 +/- 10 mg/100 ml, P < 0.01; insulin: 12.4 +/- 1.7 vs. 4.9 +/- 0.6 ng/ml, P) < 0.01), whereas pancreatic wet weight was significantly low (803 +/- 20 vs. 1,138 +/- 17 mg, P < 0.01) compared with those in the LETO rat. Pancreatic acini isolated from the OLETF rat were totally insensitive to cholecystokinin (CCK)-8 stimulation at concentrations of up to 100 nM. However, neither the responsiveness nor the sensitivity to carbamylcholine, bombesin, and secretin of the acini from the OLETF rat was altered or even increased, probably due to the larger amylase content in the OLETF rat acini compared with those of the LETO rat acini (31.5 +/- 2.0 vs. 13.0 +/- 1.1 Somogyi units/micrograms DNA, P < 0.01). The responsiveness to fluoride, a direct activator of guanine nucleotide-binding protein, in the OLETF rat acini was similar to that in the LETO rat, suggesting that the transmembrane signaling and effectors and subsequent intracellular signal transduction molecules in the OLETF rat acini are normal. Moreover, 125I-CCK binding to the acini prepared from the OLETF rat was totally absent. These present results indicate that the OLETF rat has a selective defect in the binding of CCK to its receptors on the acinar cell surface.


1990 ◽  
Vol 259 (4) ◽  
pp. G655-G665 ◽  
Author(s):  
W. H. Rowley ◽  
S. Sato ◽  
S. C. Huang ◽  
D. M. Collado-Escobar ◽  
M. A. Beaven ◽  
...  

For cholecystokinin (CCK) and the partial agonist CCK-JMV-180 [Boc-Nle28,31,CCK-(27-32)-2-phenylethyl ester], we examined their abilities to stimulate the accumulation of inositol phosphates (IP), mobilize intracellular calcium, and stimulate enzyme secretion in rat pancreatic acini. CCK-8 caused an increase in [3H]IP2 and [3H]IP3 at 10 s and a slower increase in [3H]IP1. High-pressure liquid chromatography separation demonstrated that at 10 s 100% of the increase of [3H]IP3 was IP3(1,4,5). CCK-JMV-180 caused no increase in [3H]IP3 at 10 s and only 28% of the maximal increase seen with CCK-8 at 15 min. CCK-8 caused an 11-fold increase in calcium outflux, whereas CCK-JMV-180 was only 45% as effective and 3,000 times less potent. CCK-JMV-180 antagonized the CCK-8-stimulated increase in [3H]IP3 and mobilization of intracellular calcium. CCK-8 caused an 81-fold increase at 2.5 s in IP3(1,4,5) measured by a mass radioreceptor assay and half-maximal stimulation occurred at 2 nM, whereas CCK-JMV-180 only caused a 3-fold increase. Analysis of the ability of CCK-8 or CCK-JMV-180 to stimulate enzyme secretion demonstrated that at low concentrations, each peptide stimulates enzyme secretion without causing detectable calcium mobilization, whereas at increasing peptide concentrations calcium mobilization occurs without detectable accumulation of IP3(1,4,5), but at still higher concentrations IP3(1,4,5) accumulation is finally detected. These results demonstrate that peptides that stimulate enzyme secretion by interacting with CCK receptors can cause maximal stimulation with minimal changes in calcium mobilization and maximal changes in calcium mobilization occur with minimal changes in IP3(1,4,5), suggesting marked amplification.


1992 ◽  
Vol 267 (29) ◽  
pp. 20620-20629
Author(s):  
D.C. Metz ◽  
R.J. Patto ◽  
J.E. Mrozinski ◽  
R.T. Jensen ◽  
R.J. Turner ◽  
...  

2000 ◽  
Vol 118 (4) ◽  
pp. A158
Author(s):  
Taiichi Otani ◽  
Akira Matsukura ◽  
Takeshi Takamoto ◽  
Hiroshi Usui ◽  
Yasuhito Shimizu ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A539
Author(s):  
Suresh Kame ◽  
Zhao Lu ◽  
Tom Kolodecik ◽  
Fred S. Gorelick ◽  
S. Gorelick

Pancreas ◽  
1993 ◽  
Vol 8 (4) ◽  
pp. 476-487 ◽  
Author(s):  
Wolfgang E. Schmidt ◽  
JÖRg Seebeck ◽  
Michael HÖCker ◽  
Rainer Schwarzhoff ◽  
Heiner SchÄFer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document